We studied a family in which two infants had died with massive venous thrombosis shortly after birth. Protein C antigen was undetectable by immunologic assays of plasma available from one infant. (Protein C is a potent naturally occurring anticoagulant that inactivates activated coagulation factors V and VIII). The parents, who were first cousins, both had partial protein C deficiency. Reduced protein C levels were also observed in 12 of 25 additional family members. None of the partially deficient family members (age range 4 to 70 years) had thrombotic episodes. Our data support the view that hereditary protein C deficiency is an autosomal disorder in which the homozygous state may be manifested by the virtual absence of plasma protein C and by fatal thrombosis in the neonatal period.
This article has been cited by other articles:
Preston, R. J. S., Tran, S., Johnson, J. A., Ainle, F. N., Harmon, S., White, B., Smith, O. P., Jenkins, P. V., Dahlback, B., O'Donnell, J. S.
(2009). Platelet Factor 4 Impairs the Anticoagulant Activity of Activated Protein C. J. Biol. Chem.
284: 5869-5875
[Abstract][Full Text]
Harmon, S., Preston, R. J. S., Ainle, F. N., Johnson, J. A., Cunningham, M. S., Smith, O. P., White, B., O'Donnell, J. S.
(2008). Dissociation of Activated Protein C Functions by Elimination of Protein S Cofactor Enhancement. J. Biol. Chem.
283: 30531-30539
[Abstract][Full Text]
Preston, R. J. S., Ajzner, E., Razzari, C., Karageorgi, S., Dua, S., Dahlback, B., Lane, D. A.
(2006). Multifunctional Specificity of the Protein C/Activated Protein C Gla Domain. J. Biol. Chem.
281: 28850-28857
[Abstract][Full Text]
Finigan, J. H., Dudek, S. M., Singleton, P. A., Chiang, E. T., Jacobson, J. R., Camp, S. M., Ye, S. Q., Garcia, J. G. N.
(2005). Activated Protein C Mediates Novel Lung Endothelial Barrier Enhancement: ROLE OF SPHINGOSINE 1-PHOSPHATE RECEPTOR TRANSACTIVATION. J. Biol. Chem.
280: 17286-17293
[Abstract][Full Text]
de Wouwer, M. V., Collen, D., Conway, E. M.
(2004). Thrombomodulin-Protein C-EPCR System: Integrated to Regulate Coagulation and Inflammation. Arterioscler. Thromb. Vasc. Bio.
24: 1374-1383
[Abstract][Full Text]
Deguchi, H., Yegneswaran, S., Griffin, J. H.
(2004). Sphingolipids as Bioactive Regulators of Thrombin Generation. J. Biol. Chem.
279: 12036-12042
[Abstract][Full Text]
McBane, R. D. II
(2003). Genetically Determined Procoagulant States and Heparin Use. SEMIN CARDIOTHORAC VASC ANESTH
7: 427-442
[Abstract]
Sturn, D. H., Kaneider, N. C., Feistritzer, C., Djanani, A., Fukudome, K., Wiedermann, C. J.
(2003). Expression and function of the endothelial protein C receptor in human neutrophils. Blood
102: 1499-1505
[Abstract][Full Text]
Berg, D. T., Gerlitz, B., Shang, J., Smith, T., Santa, P., Richardson, M. A., Kurz, K. D., Grinnell, B. W., Mace, K., Jones, B. E.
(2003). Engineering the proteolytic specificity of activated protein C improves its pharmacological properties. Proc. Natl. Acad. Sci. USA
100: 4423-4428
[Abstract][Full Text]
Mann, K. G., Kalafatis, M.
(2003). Factor V: a combination of Dr Jekyll and Mr Hyde. Blood
101: 20-30
[Full Text]
Deguchi, H., Fernandez, J. A., Griffin, J. H.
(2002). Neutral Glycosphingolipid-dependent Inactivation of Coagulation Factor Va by Activated Protein C and Protein S. J. Biol. Chem.
277: 8861-8865
[Abstract][Full Text]
Deguchi, H., Fernandez, J. A., Pabinger, I., Heit, J. A., Griffin, J. H.
(2001). Plasma glucosylceramide deficiency as potential risk factor for venous thrombosis and modulator of anticoagulant protein C pathway. Blood
97: 1907-1914
[Abstract][Full Text]
Matitiau, A., Tabachnik, E., Sthoeger, D., Birk, E.
(2001). Thrombus in the Left Ventricle of a Child With Systemic Emboli: An Unusual Presentation of Hereditary Protein C Deficiency. Pediatrics
107: 421-422
[Abstract][Full Text]
Nair, K S, Weerasinghe, A, Dahdal, M, Gibbs, J S. R, Anderson, J R
(2001). Cardiac intraventricular thrombus in protein C deficiency. JRSM
94: 641-642
[Full Text]
Monagle, P., Michelson, A. D., Bovill, E., Andrew, M.
(2001). Antithrombotic Therapy in Children. Chest
119
: 344S-370S
[Full Text]
Waugh, J. M., Li-Hawkins, J., Yuksel, E., Kuo, M. D., Cifra, P. N., Hilfiker, P. R., Geske, R., Chawla, M., Thomas, J., Shenaq, S. M., Dake, M. D., Woo, S. L. C.
(2000). Thrombomodulin Overexpression to Limit Neointima Formation. Circulation
102: 332-337
[Abstract][Full Text]
Gale, A. J., Heeb, M. J., Griffin, J. H.
(2000). The autolysis loop of activated protein C interacts with factor Va and differentiates between the Arg506 and Arg306 cleavage sites. Blood
96: 585-593
[Abstract][Full Text]
Gu, J.-M., Katsuura, Y., Ferrell, G. L., Grammas, P., Esmon, C. T.
(2000). Endotoxin and thrombin elevate rodent endothelial cell protein C receptor mRNA levels and increase receptor shedding in vivo. Blood
95: 1687-1693
[Abstract][Full Text]
Petaja, J., Pesonen, E., Fernandez, J. A., Vento, A. E., Ramo, O. J., Griffin, J. H.
(1999). CARDIOPULMONARY BYPASS AND ACTIVATION OF ANTITHROMBOTIC PLASMA PROTEIN C. J. Thorac. Cardiovasc. Surg.
118: 422-429
[Abstract][Full Text]
Waugh, J. M., Yuksel, E., Li, J., Kuo, M. D., Kattash, M., Saxena, R., Geske, R., Thung, S. N., Shenaq, S. M., Woo, S. L. C.
(1999). Local Overexpression of Thrombomodulin for In Vivo Prevention of Arterial Thrombosis in a Rabbit Model. Circ. Res.
84: 84-92
[Abstract][Full Text]
Kyrle, P. A., Mannhalter, C., Beguin, S., Stumpflen, A., Hirschl, M., Weltermann, A., Stain, M., Brenner, B., Speiser, W., Pabinger, I., Lechner, K., Eichinger, S.
(1998). Clinical Studies and Thrombin Generation in Patients Homozygous or Heterozygous for the G20210A Mutation in the Prothrombin Gene. Arterioscler. Thromb. Vasc. Bio.
18: 1287-1291
[Abstract][Full Text]
Yamamoto, K., Loskutoff, D. J.
(1998). Extrahepatic Expression and Regulation of Protein C in the Mouse. Am. J. Pathol.
153: 547-555
[Abstract][Full Text]
Spek, C. A., Lannoy, V. J., Lemaigre, F. P., Rousseau, G. G., Bertina, R. M., Reitsma, P. H.
(1998). Type I Protein C Deficiency Caused by Disruption of a Hepatocyte Nuclear Factor (HNF)-6/HNF-1 Binding Site in the Human Protein C Gene Promoter. J. Biol. Chem.
273: 10168-10173
[Abstract][Full Text]
Bick, R. L., Kaplan, H.
(1998). Syndromes of Thrombosis and Hypercoagulability: Congenital and Acquired Thrombophilias. CLIN APPL THROMB HEMOST
4: 25-50
[Abstract]
Dudek, A. Z., Pennell, C. A., Decker, T. D., Young, T. A., Key, N. S., Slungaard, A.
(1997). Platelet Factor 4 Binds to Glycanated Forms of Thrombomodulin and to Protein C. A POTENTIAL MECHANISM FOR ENHANCING GENERATION OF ACTIVATED PROTEIN C. J. Biol. Chem.
272: 31785-31792
[Abstract][Full Text]
Mac Hale, J. L., Nathan, N., D'Ambra, M.
(1997). Intrinsic Anticoagulation: Protein C, Protein S, and Thrombomodulin. SEMIN CARDIOTHORAC VASC ANESTH
1: 319-332
[Abstract]
Cadroy, Y., Diquelou, A., Dupouy, D., Bossavy, J.P., Sakariassen, K.S., Sie, P., Boneu, B.
(1997). The Thrombomodulin/Protein C/Protein S Anticoagulant Pathway Modulates the Thrombogenic Properties of the Normal Resting and Stimulated Endothelium. Arterioscler. Thromb. Vasc. Bio.
17: 520-527
[Abstract][Full Text]
Conway, E. M., Pollefeyt, S., Collen, D., Steiner-Mosonyi, M.
(1997). The Amino Terminal Lectin-Like Domain of Thrombomodulin Is Required for Constitutive Endocytosis. Blood
89: 652-661
[Abstract][Full Text]
Tam, D. A.
(1997). Protein C and Protein S Activity in Sickle Cell Disease and Stroke. J Child Neurol
12: 19-21
[Abstract]
van den Belt, A. G. M., Prins, M. H., Huisman, M. V., Hirsh, J.
(1996). Familial Thrombophilia: A Review Analysis. CLIN APPL THROMB HEMOST
2: 227-236
[Abstract]
Spek, C. A., Greengard, J. S., Griffin, J. H., Bertina, R. M., Reitsma, P. H.
(1995). Two Mutations in the Promoter Region of the Human Protein C Gene Both Cause Type I Protein C Deficiency by Disruption of Two HNF-3 Binding Sites. J. Biol. Chem.
270: 24216-24221
[Abstract][Full Text]
Atalay, S., Imamoglu, A., Ikizler, C., Uluoglu, O., Ocal, B.
(1995). Mitral Valve and Left Ventricular Thrombi in an Infant with Acquired Protein C Deficiency: A Case Report. ANGIOLOGY
46: 87-90
[Abstract]
Greengard, J. S., Eichinger, S., Griffin, J. H., Bauer, K. A.
(1994). Variability of Thrombosis among Homozygous Siblings with Resistance to Activated Protein C Due to an Arg-to-Gln Mutation in the Gene for Factor V. NEJM
331: 1559-1562
[Full Text]
Riela, A. R., Roach, E. S.
(1993). Topical Review Article: Etiology of Stroke in Children. J Child Neurol
8: 201-220
[Abstract]
McKnight, J. T., Maxwell, A. J., Anderson, R. L.
(1992). Warfarin Necrosis. Arch Fam Med
1: 105-108
[Abstract]
Simioni, P., Zanon, G., Lazzaro, A.R., Patrassi, G.M., Girolami, A.
(1991). Heterozygous Protein C Deficiency Associated with Multiple Congenital Hemangiomas A Case Report. ANGIOLOGY
42: 337-342
[Abstract]
Auletta, M. J., Headington, J. T.
(1988). Purpura Fulminans: A Cutaneous Manifestation of Severe Protein C Deficiency. Arch Dermatol
124: 1387-1391
[Abstract]
Tarras, S., Gadia, C., Meister, L., Roldan, E., Gregorios, J. B.
(1988). Homozygous Protein C Deficiency in a Newborn: Clinicopathologic Correlation. Arch Neurol
45: 214-216
[Abstract]
Gladson, C. L., Groncy, P., Griffin, J. H.
(1987). Coumarin Necrosis, Neonatal Purpura Fulminans, and Protein C Deficiency. Arch Dermatol
123: 1701a-1706a
[Abstract]
Esmon, C.
(1987). The regulation of natural anticoagulant pathways. Science
235: 1348-1352
[Abstract]
Teepe, R. G. C., Broekmans, A. W., Vermeer, B. J., Nienhuis, A. M., Loeliger, E. A.
(1986). Recurrent Coumarin-Induced Skin Necrosis in a Patient With an Acquired Functional Protein C Deficiency. Arch Dermatol
122: 1408-1412
[Abstract]
SCHAFER, A. I.
(1985). The Hypercoagulable States. ANN INTERN MED
102: 814-828
[Abstract]
McGEHEE, W. G., KLOTZ, T. A., EPSTEIN, D. J., RAPAPORT, S. I.
(1984). Coumarin Necrosis Associated with Hereditary Protein C Deficiency. ANN INTERN MED
101: 59-60
[Abstract]
Hackeng, T. M., Fernandez, J. A., Dawson, P. E., Kent, S. B. H., Griffin, J. H.
(2000). Chemical synthesis and spontaneous folding of a multidomain protein: Anticoagulant microprotein S. Proc. Natl. Acad. Sci. USA
97: 14074-14078
[Abstract][Full Text]
Previous
